Identification of a novel Brevibacterium species isolated from humans and description of Brevibacterium sanguinis sp. nov.

Journal of Clinical Microbiology

Volumn 42, Issue 6, 2004, Pages 2829-2832

  Wauters, Georges ^a   Haase, Gerhard ^b   Avesani, Véronique ^a   Charlier, Jacqueline ^a   Janssens, Michèle ^a   Van Broeck, Johan ^a   Delmée, Michel ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALOTIN; CEFOTAXIME; CIPROFLOXACIN; ERYTHROMYCIN; FATTY ACID; GENTAMICIN; PENICILLIN DERIVATIVE; RIBOSOME DNA; RIBOSOME RNA; RNA 16S; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; BREVIBACTERIUM; BREVIBACTERIUM SANGUINIS; CASE REPORT; CLINICAL FEATURE; DNA DNA HYBRIDIZATION; DNA SEQUENCE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPPORTUNISTIC INFECTION; PHYLOGENY; PRIORITY JOURNAL; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

BASE SEQUENCE; BREVIBACTERIUM; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, RIBOSOMAL, 16S;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); BREVIBACTERIUM; BREVIBACTERIUM CASEI; BREVIBACTERIUM SANGUINIS; HUMAN IMMUNODEFICIENCY VIRUS; UNCULTURED ACTINOMYCETE;

EID: 2942527247     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.6.2829-2832.2004     Document Type: Article

References (18)

1. Brazzola, P., R. Zbinden, C. Rudin, U. B. Schaad, and U. Heininger. 2000. Brevibacterium casei sepsis in an 18-year-old female with AIDS. J. Clin. Microbiol. 38:3513-3514.
2. Collins, M. D., J. A. E. Farrow, M. Goodfellow, and D. E. Minnikin. 1983. Brevibacterium casei sp. nov. and Brevibacterium epidermidis sp. nov. Syst. Appl. Microbiol. 4:388-395.
3. Correia, A., J. F. Martin, and J. M. Castro. 1994. Pulsed-field gel electrophoresis analysis of the genome of amino acid producing corynebacteria: chromosome sizes and diversity of restriction patterns. Microbiology 140: 2841-2847.
4. Euzéby, J. 2004. Notification list. Int. J. Syst. Bacteriol. 54:3-6.
5. Funke, G., and A. Carlotti. 1994. Differentiation of Brevibacterium spp. encountered in clinical specimens. J. Clin. Microbiol. 32:1729-1732.
6. Funke, G., A. von Graevenitz, J. E. Clarridge III, and K. A. Bernard. 1997. Clinical microbiology of coryneform bacteria. Clin. Microbiol. Rev. 10:125-159.
7. Kaukoranta-Tolvanen, S. S., A. Sivonen, A. A. Kostiala, P. Hormila, and M. Vaara. 1995. Bacteremia caused by Brevibacterium species in an immunocompromised patient. Eur. J. Clin. Microbiol. Infect. Dis. 14:801-804.
8. Knisely, R. F. 1966. Selective medium for Bacillus anthracis. J. Bacteriol. 92:784-786.
9. Laffineur, K., V. Avesani, G. Cornu, J. Charlier, M. Janssens, G. Wauters, and M. Delmée. 2003. Bacteremia due to a novel Microbacterium species in a patient with leukemia and description of Microbacterium paraoxydans sp. nov. J. Clin. Microbiol. 41:2242-2246.
10. Lina, B., A. Carlotti, V. Lesaint, Y. Devaux, J. Freney, and J. Fleurette. 1994. Persistent bacteremia due to Brevibacterium species in an immunocompromised patient. Clin. Infect. Dis. 18:487-488.
11. Martin, R., P. S. Riley, D. G. Hollis, R. E. Weaver, and M. I. Krichevsky. 1981. Characterization of some groups of gram-negative nonfermentative bacteria by the carbon source alkalinization technique. J. Clin. Microbiol. 14:39-47.
12. McBride, M. E., K. M. Ellner, H. S. Black, J. E. Clarridge, and J. E. Wolf. 1993. A new Brevibacterium sp. isolated from infected genital hair of patients with white piedra. J. Med. Microbiol. 39:255-261.
13. NCCLS. 2002. Zone diameter interpretative standards and equivalent minimal inhibitory concentration (MIC) breakpoints for Staphylococcus spp. NCCLS document M100-S12 (M2-A7 disk diffusion). National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Pascual, C., M. D. Collins, G. Funke, and D. G. Pitcher. 1996. Phenotypic and genotypic characterisation of two Brevibacterium strains from the human ear: description of Brevibacterium otitidis sp. nov. Med. Microbiol. Lett. 5:113-123.
15. Schleifer, K. H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36:407-477.
16. 2 coryneforms belong to the species Corynebacterium amycolatum. Int. J. Syst. Bacteriol. 46:653-657.
17. Wauters, G., J. Charlier, M. Janssens, and M. Delmée. 2001. Description of Brevibacterium paucivorans sp. nov. isolated from human clinical specimens Int. J. Syst. Evol. Microbiol. 51:1703-1707.
18. Wauters, G., V. Avesani, K. Laffineur, J. Charlier, M. Janssens, B. Van Bosterhaut, and M. Delmée. 2003. Brevibacterium lutescens sp. nov., from human and environmental samples. Int. J. Syst. Evol. Microbiol. 53:1321-1325.